Please note: The information displayed on this page might be outdated.
Tempest Therapeutics: Tempest Therapeutics is a development‐stage biotechnology company advancing small molecules that modulate anti‐tumor immunity pathways. The company has a balanced and deep pipeline consisting of first‐in‐class and potential best‐in‐class small molecule therapeutics that modulate distinct immune response pathways relevant to mounting an effective anti‐tumor response. Tempest’s backers include Versant Ventures, F‐Prime Capital, Quan Capital, Lilly Asia Ventures, Foresite Capital and Eight Roads Ventures.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Pre-Clinical Stage
Disease Space
Oncology
Listing
Private
Market Cap
Private
Website:
Address:
One Sansome St. Ste #3690
San Francisco, CA 94104
United States

Company Participants at Private Company Showcase NYC 2019

  • Dr. Thomas Dubensky, President & CEO